EUVIMEDEUVIMED entdecken
Crossref

Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

Rosaria M Pipitone, Francesco Malvestiti, Grazia Pennisi iD, Oveis Jamialahmadi, Paola Dongiovanni iD, Giorgio Bertolazzi, Jussi Pihlajamäki iD, Hannele Yki-Järvinen, Umberto Vespasiani-Gentilucci iD, Federica Tavaglione, Samantha Maurotti, Cristiana Bianco iD und 18 weitere

Liver International · 2023

DOI: 10.1111/liv.15586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2023. Verfasst von Rosaria M Pipitone und 29 weiteren Autor:innen. Beteiligte Einrichtung: Sezione di Gastroenterologia e Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccelle…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Programmed cell death 1/programmed cell death‐ligand 1 (PD‐1/PDL‐1) axis has been reported to modulate liver inflammation and progression to hepatocellular carcinoma (HCC) in patients with nonalcoholic fatty liver disease (NAFLD). Here, we examined whether the PDCD1 variation is associated with NAFLD severity in individuals with liver biopsy.

Methods

We examined the impact of PDCD1 gene variants on HCC, as robust severe liver disease phenotype in UK Biobank participants. The strongest genetic association with the rs13023138 G>C variation was subsequently tested for association with liver damage in 2889 individuals who underwent liver biopsy for suspected nonalcoholic steatohepatitis (NASH). Hepatic transcriptome was examined by RNA‐Seq in a subset of NAFLD individuals ( n = 121). Transcriptomic and deconvolution analyses were performed to identify biological pathways modulated by the risk allele.

Results

The rs13023138 C>G showed the most robust association with HCC in UK Biobank ( p = 5.28E‐4, OR = 1.32, 95% CI [1.1, 1.5]). In the liver biopsy cohort, rs13023138 G allele was independently associated with severe steatosis (OR 1.17, 95% CI 1.02‐1.34; p = .01), NASH (OR 1.22, 95% CI 1.09‐1.37; p < .001) and advanced fibrosis (OR 1.26, 95% CI 1.06‐1.50; p = .007). At deconvolution analysis, rs13023138 G>C allele was linked to higher hepatic representation of M1 macrophages, paralleled by upregulation of pathways related to inflammation and higher expression of CXCR6.

Conclusions

The PDCD1 rs13023138 G allele was associated with HCC development in the general population and with liver disease severity in patients at high risk of NASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsHumansLiverInflammationApoptosisLiver Cirrhosis

Stichwörter der Autor:innen

CXCR6NAFLDNASHPDCD1checkpoint inhibitors

Autor:innen und Institutionen

  • Sezione di Gastroenterologia e Epatologia, Dipartimento di Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza "G. D'Alessandro", University of Palermo, Palermo, Italy.
  • Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • General Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Tumor Immunology Unit, University of Palermo School of Medicine, Palermo, Italy.
  • Department of Clinical Nutrition, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.

ORCID-Profile: Grazia Pennisi, Paola Dongiovanni, Jussi Pihlajamäki, Umberto Vespasiani-Gentilucci, Cristiana Bianco, Gabriele Di Maria, Anna L Fracanzani, Sami Qadri, Vito Di Marco, Calogero Cammà, Luca Valenti, Stefano Romeo, Salvatore Petta

Förderung

  • Ministero dell'Istruzione, dell'Università e della Ricerca
  • Ministero dell’Istruzione, dell’Università e della Ricerca

Zitieren

APA

Pipitone, R. M., Malvestiti, F., Pennisi, G., Jamialahmadi, O., Dongiovanni, P., Bertolazzi, G., Pihlajamäki, J., Yki-Järvinen, H., Vespasiani-Gentilucci, U., Tavaglione, F., Maurotti, S., Bianco, C., Di Maria, G., Enea, M., Fracanzani, A. L., Kärjä, V., Lupo, G., Männistö, V., Meroni, M., …, & Grimaudo, S. (2023). Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease. Liver International. https://doi.org/10.1111/liv.15586

Vancouver

Pipitone RM, Malvestiti F, Pennisi G, Jamialahmadi O, Dongiovanni P, Bertolazzi G, et al. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease. Liver International. 2023. doi:10.1111/liv.15586

BibTeX
@article{Pipitone2023,
  author = {Pipitone, Rosaria M and Malvestiti, Francesco and Pennisi, Grazia and Jamialahmadi, Oveis and Dongiovanni, Paola and Bertolazzi, Giorgio and Pihlajamäki, Jussi and Yki-Järvinen, Hannele and Vespasiani-Gentilucci, Umberto and Tavaglione, Federica and Maurotti, Samantha and Bianco, Cristiana and Di Maria, Gabriele and Enea, Marco and Fracanzani, Anna L and Kärjä, Vesa and Lupo, Giulia and Männistö, Ville and Meroni, Marica and Piciotti, Roberto and Qadri, Sami and Zito, Rossella and Craxì, Antonio and Di Marco, Vito and Cammà, Calogero and Tripodo, Claudio and Valenti, Luca and Romeo, Stefano and Petta, Salvatore and Grimaudo, Stefania},
  title = {Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease},
  journal = {Liver International},
  year = {2023},
  doi = {10.1111/liv.15586}
}
Kostenlos starten →